Objectives

After participating in this educational activity, attendees should be able to:
1. Discuss current 4 Factor Prothrombin Complex Concentrate use and areas for improvement
2. Apply clinical pearls to 4 Factor Prothrombin Complex Concentrate order verification
3. Recall patient specific considerations that should be considered when prescribing warfarin

4. Discuss rivaoxaban dosing used in the PIONEER trial and its differences to currently established dosing

5. Compare and contrast pharmacokinetic differences between IV vs. oral vitamin K

Faculty

Danyel Adams, PharmD

Clinical Pharmacy Specialist, Emergency Medicine

Baystate Medical Center

Gabriela Macias, PharmD, BCPS
Clinical Pharmacy Specialist, Heart and Vascular services
Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.